Observational studyBMC infectious diseases2019

Effectiveness and safety of dual therapy with rilpivirine and boosted darunavir in treatment-experienced patients with advanced HIV infection: a preliminary 24 week analysis (RIDAR study).

Juan Pasquau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.